Skip to Main Content

Paper Details

Plasma Protein Biomarkers in Advanced or Metastatic Colorectal Cancer Patients Receiving Chemotherapy With Bevacizumab or Cetuximab: Results from CALGB 80405 (Alliance).
Clin Cancer Res
9
2022
Author NameAffiliation
Kouros OwzarDuke Cancer Institute, Duke University Medical Center
Kouros OwzarDuke University
  • 1 - 2

Datasets

Release 1.2